Colombia Freezes U.S. Arms Purchases After Trump Decertifies Nation as Anti-Drug Ally
“From this moment on… weapons will not be purchased from the United States.” — Colombian Interior Minister Armando Benedetti
A Sudden Break in a Long Alliance
Colombia, historically Washington’s closest military partner in Latin America, halted all weapons purchases from the United States on Tuesday after former U.S. President Donald Trump decertified the country as an anti-drugs ally. The move marks the first such decertification of Colombia in over three decades and threatens to shake the foundations of a security relationship built on billions of dollars in U.S. assistance since the 1980s.
On Monday, Trump accused Colombian President Gustavo Petro of failing to curb cocaine production, saying output had surged to “all-time records” under Petro’s watch. He declared Colombia had “failed demonstrably to meet its drug control obligations,” a designation with both symbolic and diplomatic weight.
Colombian Response: Rejection of U.S. Dependency
Colombian Interior Minister Armando Benedetti fired back in an interview with Blu Radio, announcing the suspension of arms purchases from the United States. President Petro, himself a former leftist guerrilla, framed the break as a step toward sovereignty, vowing that Colombia’s military would no longer rely on what he called “handouts” from Washington.
Petro has been pushing to reframe global drug policy since taking office in 2022, shifting away from forced coca eradication toward addressing social and economic drivers of trafficking. Under his tenure, coca cultivation has risen roughly 70 percent, according to both Colombian government and United Nations data. Petro argues the problem is global, pointing to Europe’s rising cocaine consumption and the U.S. shift to fentanyl, which he called “30 times more deadly.”
U.S. Rebuke and Political Undercurrents
The Trump administration’s decision was widely interpreted as a political rebuke of Petro’s drug policy rather than a cut in material support. U.S. funding for Colombian anti-narcotics operations, about $380 million annually, is not expected to be withdrawn. Still, the decertification carries symbolic weight, signaling Washington’s dissatisfaction with a government long viewed as a cornerstone of the regional drug war.
Secretary of State Marco Rubio, speaking during a trip to Israel, underscored the political fracture. “Colombia has been a great partner historically,” Rubio said. “Unfortunately, they have a president now that, in addition to being erratic, has not been a very good partner when it comes to taking on the drug cartels.”
Rising Violence at Home
The fallout comes as Colombia faces a surge in violence from armed groups financed by drug profits. On August 21, twelve police officers were killed when dissident factions of the defunct FARC rebels shot down a police helicopter during a coca eradication mission in the northwest. The attack highlighted the mounting risks faced by Colombia’s security forces even as the government debates new strategies for tackling the drug trade.
A Strained Future for U.S.-Colombia Relations
Washington has conducted annual drug-control certifications since 1986, reviewing roughly 20 countries each year. Colombia’s decertification under Trump marks a sharp turn in a relationship that, for decades, formed the backbone of U.S. anti-narcotics efforts in the hemisphere.
For Petro, however, the moment may represent an opportunity to redefine Colombia’s role in the global fight against drugs, away from being Washington’s enforcement arm and toward becoming a voice for international policy reform. Whether Colombia can navigate this shift without worsening violence or losing critical U.S. security assistance remains an open question.
Sources
